Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Bifidobacterium longum bacteremia in preterm infants receiving probiotics.

  • 2014-12-03
  • Clinical Infectious Diseases 60(6)
    • C. Bertelli
    • T. Pillonel
    • Anaïs Torregrossa
    • G. Prod'Hom
    • C. Fischer
    • Gilbert GREUB
    • E. Giannoni

Abstract

Administration of probiotics to premature newborns has been shown to prevent necrotizing enterocolitis and reduce all-cause mortality. In our hospital, we documented 2 cases of Bifidobacterium longum subspecies infantis bacteremia in newborns receiving probiotics. By comparative genomics, we confirmed that the strains isolated from each patient originated from the probiotics.

Keywords: Bifidobacterium; genome sequence; newborn; probiotics; sepsis.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bifidobacterium infantisSepsis Management ImprovementHarmful
Large
Bifidobacterium infantis BI02Reduced Bacteremia IncidenceHarmful
Moderate
Bifidobacterium infantis VPro 53Bifidobacterium longum infantis BacteremiaHarmful
Moderate
Bifidobacterium infantis VPro 53Prevention of Necrotising EnterocolitisBeneficial
Moderate
Bifidobacterium infantis VPro 53Reduced All-Cause MortalityBeneficial
Moderate
Bifidobacterium longum subsp. infantisReduced Bacteremia in Preterm InfantsHarmful
Moderate
Back to top